z-logo
open-access-imgOpen Access
Subcutaneous Daratumumab With Standard Therapy in Multiple Myeloma
Author(s) -
Vincent Vidaurri
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615304.83235.c8
Subject(s) - daratumumab , lenalidomide , medicine , multiple myeloma , bortezomib , clinical endpoint , dexamethasone , oncology , surgery , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here